喘-慢性阻塞性肺病重叠:来自全国多中心研究的结果
Gülfem Elif Çelik1, Ömür Aydin1, Elif Şen2
1Division of Immunology and Allergy, Department of Chest Diseases, Ankara University Faculty of Medicine, Ankara, Türkiye.
Tuberkuloz ve toraks
|April 27, 2024
概括
喘-COPD重叠 (ACO) 影响了土耳其20.8%的喘或COPD患者. 这种情况具有独特的临床特征和更快的肺功能下降,需要在临床实践中考虑.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床流行病学临床流行病学
背景情况:
- 喘 - 慢性阻塞性肺病 (COPD) 重叠 (ACO) 是一个重大的临床挑战,与单独喘或COPD相比,其疾病负担更高.
- 关于土耳其ACO的流行率和特征,国家数据有限.
- 了解ACO对于有效的患者管理和资源分配至关重要.
研究的目的:
- 确定在土耳其诊断患有喘或COPD的患者中ACO的患病率.
- 为了确定与ACO相关的风险因素.
- 描述ACO.CO患者的临床特征和疾病进展.
主要方法:
- 在土耳其的九家三级医院进行了一项横截面研究.
- 那些被诊断患有喘或慢性肺炎至少一年的患者被纳入.
- 收集和分析了患者人口统计,病史,临床特征和肺功能 (FEV1下降) 的数据.
主要成果:
- ACO的总体患病率为20.8% (在408名受试者中85名).
- 在COPD组中,ACO的发生率比喘组 (9.8%) 高 (33.3%).
- ACO患者具有COPD (老年,吸烟,农村背景) 和喘 (儿童喘病史,过敏,高乙蛋白) 的共同特征,并且FEV1 (-250毫升) 的年度下降更明显.
结论:
- 喘-COPD重叠 (ACO) 在土耳其的第三级护理机构中很普遍.
- ACO患者表现出一种独特的表型,具有喘和COPD的特征.
- 临床医生应考虑在出现喘和COPD重叠症状的患者中使用ACO.
相关概念视频
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:26Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K